Research location
Cascais
Portugal
Advertisement
Research activity in Cascais
PortugalCureCurrent currently publishes aggregate city-level research activity for this location: 18 trials and 18 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cascais
18 linked trials · page 1 of 1Prevalence and Characterisation of Asthma Patients According to Disease Severity in PortugalNCT05169619 · 2021-04-30 · 1 site observation
COMPLETED
Expanded Access Program for Maraviroc At Multiple CentersNCT00426660 · 2007-02-01 · 1 site observation
COMPLETED
Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive AdultsNCT00389207 · 2006-10-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityNCT00340080 · 2006-04-01 · 1 site observation
COMPLETED
Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)NCT00207142 · 2005-11-01 · 1 site observation
COMPLETED
Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected PeopleNCT00110812 · 2005-09-01 · 1 site observation
COMPLETED
A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced AdultsNCT00242879 · 2005-08-01 · 1 site observation
TERMINATED
GW873140 In Combination With Kaletra In HIV Infected SubjectsNCT00102778 · 2004-12-01 · 1 site observation
TERMINATED
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksNCT00085943 · 2004-05-01 · 1 site observation
COMPLETED
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyNCT00256698 · 2004-01-01 · 1 site observation
COMPLETED
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionNCT00062660 · 2003-05-01 · 1 site observation
APPROVED_FOR_MARKETING
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsNCT00056641 · 2003-02-18 · 1 site observation
COMPLETED
Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)NCT00144170 · 2003-02-01 · 1 site observation
COMPLETED
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsNCT00044577 · 2002-07-16 · 1 site observation
COMPLETED
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected SubjectsNCT00146328 · 2001-04-01 · 1 site observation
COMPLETED
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral TherapyNCT00004978 · 2000-03-01 · 1 site observation
COMPLETED
Collection of Blood Samples From SMART Study Participants for Future Genetic StudiesNCT00377169 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.